TFRC and cancer: Consequently, a wide spectrum of cellular receptors and proteins, including transferrin receptor, insulin-like growth factor 1 (IGF-1) receptor, folate receptor or integrins has been widely investigated to date as factors for increasing drug selectivity against cancer cells [77].